SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-072542
Filing Date
2012-10-31
Accepted
2012-10-31 10:15:56
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-20266_110q.htm 10-Q 490983
2 EX-31.1 a12-20266_1ex31d1.htm EX-31.1 12960
3 EX-31.2 a12-20266_1ex31d2.htm EX-31.2 12993
4 EX-32 a12-20266_1ex32.htm EX-32 7791
  Complete submission text file 0001104659-12-072542.txt   4900335

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT imgn-20120930.xml EX-101.INS 507587
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imgn-20120930.xsd EX-101.SCH 63564
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imgn-20120930_cal.xml EX-101.CAL 47794
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imgn-20120930_def.xml EX-101.DEF 369817
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT imgn-20120930_lab.xml EX-101.LAB 937998
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imgn-20120930_pre.xml EX-101.PRE 509517
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 121169828
SIC: 2834 Pharmaceutical Preparations